Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 4:7:e5652.
doi: 10.7717/peerj.5652. eCollection 2019.

Changes in interleukin-27 levels in patients with acute coronary syndrome and their clinical significance

Lin Zhang  1 , Junfeng Zhang  1 , Shaohong Su  1 , Suyan Luo  1
Affiliations

Changes in interleukin-27 levels in patients with acute coronary syndrome and their clinical significance

Lin Zhang et al. PeerJ. .

Abstract

Background: This study evaluated changes in interleukin (IL)-27 levels in patients with acute coronary syndrome (ACS) and their influence on Th1, Th2, and Th17 cells.

Methods: Serum levels of IL-27, IL-4, IL-17, and interferon (IFN)-γ in healthy subjects as well as patients with ACS, including stable angina pectoris (SA), unstable angina pectoris (UA), and acute myocardial infarction (AMI), were determined using an enzyme-linked immunosorbent assay. The proportions of Th1, Th2, and Th17 cells among peripheral blood mononuclear cells (PBMCs), were measured using flow cytometry, after incubation with phorbol myristate acetate (PMA) for 4 h. The proportions of Th1 and Th17 cells among PBMCs in AMI and UA were detected after stimulation with IL-27 or PMA + IL-27 for 4, 8, and 12 h.

Results: Serum levels of IL-27 in patients with AMI and UA were significantly lower than those in SA and control groups, while serum levels of IL-17 and IFN-γ in AMI and UA groups were dramatically increased compared to those in SA and healthy control groups. However, there were no statistically significant differences in serum IL-4. The proportions of Th1 and Th17 cells among PBMCs were statistically significantly higher in the AMI and UA groups than those in the SA and control groups, while there was no statistically significant difference in the proportion of Th2 cells among different groups. For patients with AMI and UA, the effect of co-stimulation of PBMCs with PMA and IL-27 was not significantly different from that of PMA single stimulation, while PMA + IL-27 co-stimulation lowered the Th17 cell proportion significantly compared to PMA single stimulation.

Discussion: Compared to SA patients and healthy controls, patients with ACS (AMI + UA) had lower serum levels of IL-27 and higher proportions of PBMC Th1 and Th17 cells, which could be attributed to the inhibitory effects of IL-27 on the proliferation of Th17 cells. These results indicated that IL-27 could be a novel therapeutic target in ACS patients.

Keywords: Acute coronary syndrome; IL-27; Th2 cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare there are no competing interests.

Figures

Figure 1
Figure 1. Levels of IL-27, IL-4, IL-17 and INF-γ in serums of patients in different groups.
Figure 2
Figure 2. Percentages of TH1, Th2 and Th17 cells in different groups after incubated with PMA for 4 h.
Figure 3
Figure 3. Percentage of Th1, Th17 cells in AMI, UA group when cells were incubated with PMA in IL-2.
See this image and copyright information in PMC

References

    1. Al Shahi H, Shimada K, Miyauchi K, Yoshihara T, Sai E, Shiozawa T, Naito R, Aikawa T, Ouchi S, Kadoguchi T. Elevated circulating levels of inflammatory markers in patients with acute coronary syndrome. International Journal of Vascular Medicine. 2015;2015:805375. - PMC - PubMed
    1. Behzadi P, Behzadi E, Ranjbar R. IL-12 family cytokines: general characteristics, pathogenic microorganisms, receptors, and signalling pathways. Acta Microbiologica et Immunologica Hungarica. 2016;63:1–25. doi: 10.1556/030.63.2016.1.1. - DOI - PubMed
    1. Boivin N, Baillargeon J, Doss PM, Roy AP, Rangachari M. Interferon-beta suppresses murine Th1 cell function in the absence of antigen-presenting cells. PLOS ONE. 2015;10:e0124802. doi: 10.1371/journal.pone.0124802. - DOI - PMC - PubMed
    1. Cui B, Lu S, Lai L, Xie Y, He J, Xue Y, Xiao P, Pan T, Chen L, Liu Y. Protective function of interleukin 27 in colitis-associated cancer via suppression of inflammatory cytokines in intestinal epithelial cells. Oncoimmunology. 2017;6:e1268309. doi: 10.1080/2162402X.2016.1268309. - DOI - PMC - PubMed
    1. Dong M, Zhou C, Ji L, Pan B, Zheng L. AG1296 enhances plaque stability via inhibiting inflammatory responses and decreasing MMP-2 and MMP-9 expression in ApoE-/-mice. Biochemical and Biophysical Research Communications. 2017;489:426–431. doi: 10.1016/j.bbrc.2017.05.159. - DOI - PubMed

LinkOut - more resources